Marcos Cardoso Rios

Marcos Cardoso Rios

Auto-generated profile, based on publicly available information

Marcos Cardoso Rios

Pharmacy Department, Laboratory of Teaching and Research in Social Pharmacy, Federal University of Sergipe, São Cristóvão, Brazil

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Biological Research
Verified
Journal Article
Open access
PDF file
PFPaulo A Farias-Junior
Paulo A Farias-Junior
MRMarcos C Rios
Marcos C Rios
TMTauanny A Moura
Tauanny A Moura
RARoque P Almeida
Roque P Almeida
PAPericles B Alves
Pericles B Alves
RSRicardo Scher
Ricardo Scher
Leishamaniasis is a disease that affects more than 2 million people worldwide, whose causative agent is Leishmania spp. The current therapy for leishmaniasis is far from satisfactory. All available drugs, including pentavalent antimony, require parenteral administration and are potentially toxic. Moreover, an increase in clinical resistance to these drugs has been reported. In this scenario, plant essential oils used traditionally in folk medicine are emerging as alternative sources for chemotherapeutic compounds. In this study, in vitro leishmanicidal effects of a thymol- and a carvacrol-rich essential oil from leaves of Lippia sidoides Cham. were investigated. The essential oils were extracted and their constituents were characterized by gas chromatography coupled to mass spectrometry (GC/MS). Both essential oils showed significant activity against promastigote forms of Leishmania chagasi. However, we found that carvacrol-rich essential oil was more effective, with IC50/72 h of 54.8 μg/mL compared to 74.1 μg/mL for thymol-rich oil. Carvacrol also showed lower IC50 than thymol. Our data suggest that L. sidoides essential oils are indeed promising sources of leishmanicidal compounds.

21 April 2023 in JMIR Research Protocols
Verified
Journal Article
Open access
FAFábio Jorge Ramalho de Amorim
Fábio Jorge Ramalho de Amorim
FVFernanda Valença-Feitosa
Fernanda Valença-Feitosa
MRMarcos Cardoso Rios
Marcos Cardoso Rios
CSCarlos Adriano Santos Souza
Carlos Adriano Santos Souza
IBIzadora Menezes da Cunha Barros
Izadora Menezes da Cunha Barros
DLDivaldo Pereira de Lyra-Júnior
Divaldo Pereira de Lyra-Júnior
Background: The clinical activities developed by pharmacists in a hospital environment can improve health outcomes and generate savings for hospitals. However, to determine whether pharmaceutical interventions are cost effective, it is essential to define a method according to which cost-effectiveness is intended to be measured. In addition, the quality of economic assessments and the amount of information present in systematic reviews in the literature make it difficult to analyze the effects of this intervention. Objective: This paper aims to provide an overview of systematic reviews on the pharmacoeconomic impact of the performance of pharmaceutical care in hospitals. Methods: A systematic search of the Cochrane Library databases, PubMed or MEDLINE, LILACS, Scopus, Web of Science, Google Scholar, and Open Thesis will be performed using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. The search will involve the use of keywords determined using the Medical Subject Headings database to define the search terms and include the following terms: “pharmacoeconomics,” “pharmaceutical care,” and “hospital.” The study designs to be included will be systematic reviews of good quality. Studies will be included that address pharmacoeconomics; studies that evaluated pharmaceutical care in hospitals; and studies published in Portuguese, English, or Spanish. The primary outcome sought in the systematic reviews will be the cost ratio in monetary units and the outcomes in monetary or natural units. The secondary economic outcomes considered will be determined based on factors associated with the drugs and translated into benefit, efficacy, or utility. Results: It is intended to start this overview in January 2023. Thus far, only previous searches have been carried out to contextualize the theme and build the protocol. Conclusions: This overview will determine the pharmacoeconomic impact of pharmaceutical care interventions in the hospital environment. In addition, this study will point out which clinical outcomes in natural units are impacted by the performance of pharmaceutical care and the strengths and limitations of each approach. It will also identify gaps in the literature and areas for future work. Trial Registration: PROSPERO CRD42019140665; https://tinyurl.com/bddwnz43

18 December 2014 in Infarma - Ciências Farmacêuticas
Verified
Journal Article
Open access
PDF file
KSKathlyn Pinheiro dos Santos
Kathlyn Pinheiro dos Santos
MCMonia Carla Machado Costa
Monia Carla Machado Costa
MRMarcos Cardoso Rios
Marcos Cardoso Rios
PRPriscila Souza de Sena Rios
Priscila Souza de Sena Rios
Estudos têm demonstrado que algumas das complicações da Hipertensão Arterial e Diabetes mellitus seriam preveníveis com os serviços de atenção básica e mudança de atitude do paciente. Com vistas à diminuição dos problemas associados à farmacoterapia o Hiperdia aparece como alvo estratégico. Ainda assim, os problemas de adesão acontecem. O objetivo do estudo é verificar o grau de adesão à farmacoterapia e conhecimento dos pacientes portadores de Hipertensão e Diabetes mellitus tipo 2 atendidos em uma Unidade Básica de Saúde em Aracaju/SE. Pacientes com hipertensão e diabetes mellitus apresentaram o mesmo índice (79%) de acertos e por isso foram classificados, segundo teste de Batalla, como cumpridores do tratamento medicamentoso. Outro aspecto importante para o entendimento dos fatores que associam o baixo grau de adesão é a análise do teste de Morisky e Green (1986). De acordo com o teste, apenas 15% dos pacientes foram classificados como aderentes ao tratamento medicamentoso. Resultados mais expressivos foram de pacientes que apresentaram baixo grau de adesão, com perfil semelhante ao de ambas as intencionalidades. Como os fatores educacionais estão envolvidos, torna-se necessário que estratégias educativas adequadas a estes grupos sejam realizadas, visando o esclarecimento sobre Hipertensão Arterial e Diabetes mellitus.

20 December 2021 in JMIR Preprints
Verified
Preprint
Open access
FAFábio Jorge Ramalho de Amorim
Fábio Jorge Ramalho de Amorim
FVFernanda Valença-Feitosa
Fernanda Valença-Feitosa
MRMarcos Cardoso Rios
Marcos Cardoso Rios
CSCarlos Adriano Santos Souza
Carlos Adriano Santos Souza
IBIzadora Menezes da Cunha Barros
Izadora Menezes da Cunha Barros
DLDivaldo Pereira de Lyra-Júnior
Divaldo Pereira de Lyra-Júnior
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The clinical activities developed by pharmacists in a hospital environment can improve health outcomes and generate savings for hospitals. However, to determine whether pharmaceutical interventions are cost effective, it is essential to define a method according to which cost-effectiveness is intended to be measured. In addition, the quality of economic assessments and the amount of information present in systematic reviews in the literature make it difficult to analyze the effects of this intervention. Objective: This paper aims to provide an overview of systematic reviews on the pharmacoeconomic impact of the performance of pharmaceutical care in hospitals. Methods: A systematic search of the Cochrane Library databases, PubMed or MEDLINE, LILACS, Scopus, Web of Science, Google Scholar, and Open Thesis will be performed using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. The search will involve the use of keywords determined using the Medical Subject Headings database to define the search terms and include the following terms: “pharmacoeconomics,” “pharmaceutical care,” and “hospital.” The study designs to be included will be systematic reviews of good quality. Studies will be included that address pharmacoeconomics; studies that evaluated pharmaceutical care in hospitals; and studies published in Portuguese, English, or Spanish. The primary outcome sought in the systematic reviews will be the cost ratio in monetary units and the outcomes in monetary or natural units. The secondary economic outcomes considered will be determined based on factors associated with the drugs and translated into benefit, efficacy, or utility. Results: It is intended to start this overview in January 2023. Thus far, only previous searches have been carried out to contextualize the theme and build the protocol. Conclusions: This overview will determine the pharmacoeconomic impact of pharmaceutical care interventions in the hospital environment. In addition, this study will point out which clinical outcomes in natural units are impacted by the performance of pharmaceutical care and the strengths and limitations of each approach. It will also identify gaps in the literature and areas for future work. Trial Registration: PROSPERO CRD42019140665; https://tinyurl.com/bddwnz43